American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and

Pierre Couppié1, Christine Aznar, Bernard Carme

  • 1Service de Dermatologie, French Guiana, Centre Hospitalier de Cayenne, Centre Hospitalier de Cayenne, Cayenne, French Guiana. couppie.pierre@voila.fr

Abstract

Insights

Histoplasmosis diagnosis and treatment vary across the Americas, especially in HIV patients. Early diagnosis and accessible treatments are crucial for managing this systemic fungal infection, particularly in resource-limited settings.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Public Health

Background:

  • Histoplasmosis, caused by Histoplasma capsulatum var capsulatum, is a common systemic fungal infection in the Americas.
  • Diagnostic and therapeutic approaches for histoplasmosis differ between North and South America.
  • Disseminated histoplasmosis is an AIDS-defining illness, necessitating evaluation of prognostic factors for severe cases.

Purpose of the Study:

  • To evaluate prognostic factors for severe histoplasmosis presentations to guide initial therapeutic choices.
  • To highlight regional differences in histoplasmosis diagnosis and treatment between North and South America.
  • To address the challenges of diagnosing and treating co-infections like tuberculosis and histoplasmosis in HIV patients, especially in resource-poor settings.

Main Methods:

  • Review of diagnostic and therapeutic options for histoplasmosis.
  • Analysis of prognostic factors in patients with disseminated infections, particularly those with HIV.
  • Comparison of clinical presentations and isolate virulence between North and South American strains.

Main Results:

  • Patients with HIV and disseminated histoplasmosis with severe pulmonary and renal impairment have a poor prognosis.
  • Cutaneous presentations are more common in HIV patients in South America, where isolates show greater virulence compared to North American strains.
  • Diagnostic delays in resource-poor countries contribute to disparities in outcomes.

Conclusions:

  • Direct examination of stained smears is a simple diagnostic method in resource-limited settings.
  • Further studies on prognostic factors are needed to guide the choice between amphotericin B and itraconazole.
  • Accessible generic medications and improved diagnostic/therapeutic strategies are vital for resource-poor countries, especially for co-infections like tuberculosis and histoplasmosis in HIV patients.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...